Wall Street Journal Recognizes BioElectronics |
 |
 |
| By BiomedReports Staff | |
| Monday, 14 September 2009 03:00 | |
 BioElectronics (OTC:BIEL) has been recognized by the The Wall Street Journal 2009 Technology Innovation Awards.
BIEL was awarded a runner-up position in the Medical Devices segment. The Technology Innovation Awards are given annually for technological breakthroughs in areas such as medicine, software, Internet applications, wireless and consumer electronics. Innovations can be in the form of new products, patents, inventions or services and should break conventional processes and go beyond marginal improvements in existing products and services.
Richard Staelin, Chairman of the Board of BioElectronics, said in a press release, "We are gratified that such a prestigious organization has validated the work of BioElectronics management to bring our innovative technology to market. For a start-up of our size, it is exciting to be on a winners list that includes this year established technology leaders like Abbot Labs, HP, Qualcomm, National Semiconductor, Intel and NASA. The Wall Street Journal said that they received almost 500 nominations from around the world and selected only 36 winners." 2009 notable winners include organizations such as Abbott Laboratories (NYSE:ABT), Hewlett Packard (NYSE:HPQ), Motorola (NYSE:MOT), Intel (NASDAQ:INTC), VM Ware (NYSE:VMW) and NASA. Earlier this summer, the U.S. Patent and Trademark Office issued a significant new patent which protects BioElectronics Corp's systems and techniques for applying an electromagnetic field to bodily tissue including a self-contained and portable electromagnetic field generating device disposed over a surface of bodily tissue. PEMF technology has been proven safe and effective in hundreds of peer-reviewed scientific studies, but until now PEMF devices had been very expensive large devices and usually based in clinical settings such as clinics or hospitals. Through their use of advanced micro-circuitry the engineers at BioElectronics have shrunk this technology into a wafer-thin device that can be worn directly on the skin to relieve pain, swelling and speed healing. A complete list of all the winners can be found at the link below: http://s.wsj.net/public/resources/documents/Innovation-Awards-Winners.pdf BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites            |
about 3 hours ago
Medgenics ($MDGN) up 10% on Monday! We first told you about the firm last Friday: http://t.co/aD50CMSH
about 3 hours ago
Thinly traded BioLineRx shares move on hepatitis C deal: The shares of thinly traded BioLineRx (NASDAQ:BLRX) soa... http://t.co/ugbuZgNN
about 7 hours ago
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment; Acorda Announces Launch of Generic ... http://t.co/vSt6VrLP
about 12 hours ago
$CVM up 17% and technically looks like it may head higher.
about 17 hours ago
$ANAC drops after GlaxoSmithKline (GSK) pauses enrollment for its clinical trials of its urinary tract infection drug. http://t.co/yUUSzkUr
about 18 hours ago
Catalysts on tap for Corcept: Corcept Therapeutics (NASDAQ:CORT) is a drug discovery company focused on the deve... http://t.co/jd3C1ddH
about 19 hours ago
Commented on: "Will Celsion's Upcoming Catalysts Help The Price Break-Out Stick?" http://t.co/dJ0reUFR $BSX $PHG $MDSO $CLSN
about 19 hours ago
Monday morning watch -- European Leaders Maintain Pressure on Greece to Complete Terms for Bailout - http://t.co/0wipY6QB via @BloombergNews
Free Phone Trade Alerts
